SYNJ1 — Synaptojanin 1

Migration, Crosslink

📖

SYNJ1 — Synaptojanin 1

active

wiki page Created: 2026-04-02T07:19:30 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-synj1

📖 Wiki Page

gene2470 wordssynced 2026-04-02

SYNJ1 — Synaptojanin 1

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">SYNJ1 — Synaptojanin 1</th>
</tr>
<tr>
<td class="label">Feature</td>
<td>SYNJ1</td>
</tr>
<tr>
<td class="label">Amino acids</td>
<td>1,428</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Neuron-enriched</td>
</tr>
<tr>
<td class="label">Sac1 domain</td>
<td>Yes</td>
</tr>
<tr>
<td class="label">5-phosphatase domain</td>
<td>Yes</td>
</tr>
<tr>
<td class="label">Brain function</td>
<td>Synaptic vesicles</td>
</tr>
<tr>
<td class="label">Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Cerebral Cortex</td>
<td>High</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>Medium</td>
</tr>
<tr>
<td class="label">Striatum</td>
<td>Medium</td>
</tr>
<tr>
<td class="label">Substantia nigra</td>
<td>Medium</td>
</tr>
<tr>
<td class="label">Mutation</td>
<td>Type</td>
</tr>
<tr>
<td class="label">p.R258Q</td>
<td>Missense</td>
</tr>
<tr>
<td class="label">p.G517D</td>
<td>Missense</td>
</tr>
<tr>
<td class="label">p.Y888C</td>
<td>Missense</td>
</tr>
<tr>
<td class="label">Null alleles</td>
<td>Nonsense/splice</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a

...

SYNJ1 — Synaptojanin 1

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">SYNJ1 — Synaptojanin 1</th>
</tr>
<tr>
<td class="label">Feature</td>
<td>SYNJ1</td>
</tr>
<tr>
<td class="label">Amino acids</td>
<td>1,428</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Neuron-enriched</td>
</tr>
<tr>
<td class="label">Sac1 domain</td>
<td>Yes</td>
</tr>
<tr>
<td class="label">5-phosphatase domain</td>
<td>Yes</td>
</tr>
<tr>
<td class="label">Brain function</td>
<td>Synaptic vesicles</td>
</tr>
<tr>
<td class="label">Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Cerebral Cortex</td>
<td>High</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>Medium</td>
</tr>
<tr>
<td class="label">Striatum</td>
<td>Medium</td>
</tr>
<tr>
<td class="label">Substantia nigra</td>
<td>Medium</td>
</tr>
<tr>
<td class="label">Mutation</td>
<td>Type</td>
</tr>
<tr>
<td class="label">p.R258Q</td>
<td>Missense</td>
</tr>
<tr>
<td class="label">p.G517D</td>
<td>Missense</td>
</tr>
<tr>
<td class="label">p.Y888C</td>
<td>Missense</td>
</tr>
<tr>
<td class="label">Null alleles</td>
<td>Nonsense/splice</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/parkinson" style="color:#ef9a9a">Parkinson</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">41 edges</a></td>
</tr>
</table>

SYNJ1 (Synaptojanin 1) is a phosphoinositide phosphatase critical for synaptic vesicle endocytosis and recycling. Located on chromosome 21q22.11, this gene encodes a 1,428-amino acid protein with specialized domains that regulate phosphoinositide metabolism at presynaptic terminals. SYNJ1 functions as a key regulator of phosphoinositide signaling, and recessive mutations cause early-onset Parkinsonism with variable phenotypes, including atypical features such as seizures and developmental delay[@mcintire2012][@cremona1999].

The protein contains two conserved phosphatase domains — a Sac1 domain that dephosphorylates PI(4)P and PI(3)P, and an INPP5 domain that specifically hydrolyzes PI(4,5)P₂. These activities are essential for proper clathrin-mediated endocytosis and synaptic vesicle recycling. The identification of SYNJ1 mutations as a cause of familial Parkinson's disease established defects in synaptic vesicle recycling as a key pathway in neurodegeneration[@quadri2017].

Gene and Protein Structure

Gene Organization

The SYNJ1 gene consists of 31 exons spanning approximately 34 kb of genomic DNA on chromosome 21q22.11. The gene encodes a protein of 1,428 amino acids with a molecular weight of approximately 165 kDa.

Protein Domain Architecture

SYNJ1 contains several distinct functional domains:

N-terminal Sac1 domain (amino acids 81-280): A phosphoinositide phosphatase that dephosphorylates PI(4)P to PI and PI(3)P to PI. This domain provides the basal phosphatase activity essential for cellular phosphoinositide homeostasis.
Central 5-phosphatase domain (amino acids 600-900): Specifically hydrolyzes the 5-phosphate from PI(4,5)P₂ and PI(3,4,5)P₃. This domain is critical for synaptic vesicle endocytosis, as PI(4,5)P₂ removal is required for clathrin coat disassembly.
Proline-rich region (amino acids 1000-1200): Contains multiple PXXP motifs that interact with SH3 domain-containing proteins. This region mediates interactions with endocytic scaffolding proteins including endophilins and dynamin.
C-terminal region (amino acids 1200-1428): Contains additional protein-protein interaction motifs and regulatory sequences.

Domain Comparison with SYNJ2

SYNJ1 shares structural similarity with SYNJ2 (synaptojanin 2):

Cellular Functions

Phosphoinositide Metabolism

SYNJ1 is a master regulator of phosphoinositide signaling at the synapse:

PI(4,5)P₂ dephosphorylation: The 5-phosphatase domain converts PI(4,5)P₂ to PI(4)P, a critical step in synaptic vesicle uncoating

PI(4)P metabolism: The Sac1 domain further dephosphorylates PI(4)P to PI

PI(3)P regulation: The Sac1 domain also acts on PI(3)P, affecting endosomal function

Phosphoinositide dynamics: Maintains the balance between different phosphoinositide species

Clathrin-Mediated Endocytosis

SYNJ1 plays essential roles in clathrin-mediated endocytosis:

Vesicle scission: PI(4,5)P₂ removal facilitates the release of clathrin-coated vesicles from the plasma membrane

Uncoating: After scission, SYNJ1 collaborates with auxilin and Hsc70 to remove the clathrin coat

Vesicle recycling: The product PI(4)P regulates the reformation of synaptic vesicles

Cargo sorting: Phosphoinositide metabolism influences which cargo is internalized

Synaptic Vesicle Cycle

At the presynaptic terminal, SYNJ1 coordinates:

Vesicle endocytosis: Required for recovery of synaptic vesicle membranes after exocytosis
Vesicle reformation: PI(4)P levels regulate the generation of new synaptic vesicles
Vesicle priming: PI(4,5)P₂ dynamics affect the readiness of vesicles for release
Endophilin recruitment: SYNJ1 interacts with endophilins to mediate membrane curvature

Endosomal Function

Beyond synaptic vesicles, SYNJ1 regulates:

Early endosome dynamics: PI(4,5)P₂ and PI(3)P metabolism affects endosomal trafficking
Lysosomal function: PI(3)P levels influence autophagosome-lysosome fusion
Cargo sorting: Phosphoinositides determine cargo trafficking decisions

Role in Parkinson's Disease

Genetics

SYNJ1 mutations cause two distinct clinical presentations:

Autosomal recessive early-onset parkinsonism (PARK9):

Inheritance: Biallelic loss-of-function mutations
Key mutations: p.R258Q, p.G517D, p.Y888C[@olgiati2014]
Age of onset: Typically before age 20
Phenotype: Progressive parkinsonism with possible additional features

Phospholipase 2G6-associated neurodegeneration (PLAN):

Biallelic null mutations cause a more severe phenotype
Childhood onset
Additional features including seizures, optic atrophy, cognitive decline

Pathogenic Mechanisms

SYNJ1 mutations cause disease through several mechanisms:

PI(4,5)P₂ accumulation: Impaired dephosphorylation leads to phosphoinositide imbalance

Endocytic blockade: Clathrin coat cannot properly disassemble

Synaptic vesicle depletion: Reduced vesicle pools impair neurotransmission

α-Synuclein accumulation: Impaired autophagy leads to protein aggregation[@gong2018]

Dopaminergic neuron death: Progressive neurodegeneration

Mermaid diagram (expand to render)

Interaction with Other PD Genes

SYNJ1 intersects with multiple Parkinson's disease pathways:

LRRK2: Both affect synaptic function and endosomal trafficking
DNAJC6: Another synaptic endocytosis gene mutated in PD
DNAJC13: Related endosomal chaperone
GBA: Lysosomal dysfunction in SYNJ1 deficiency overlaps with GBA pathways

Molecular Mechanisms of Neurodegeneration

Synaptic Dysfunction

SYNJ1 deficiency causes several synaptic defects:

Vesicle pool depletion: Reduced number of synaptic vesicles available for release

Release probability changes: Altered probability of vesicle release

Endocytosis slowing: Delayed recovery after sustained activity

Vesicle size changes: Abnormal vesicle morphology

Phosphoinositide Imbalance

The phosphoinositide alterations in SYNJ1 deficiency affect:

Membrane composition: Altered phosphoinositide ratios change membrane properties
Protein localization: Many synaptic proteins require specific phosphoinositides
Signal transduction: Phosphoinositides are second messengers
Cytoskeleton: PI(4,5)P₂ affects actin dynamics

Autophagy Impairment

SYNJ1 deficiency disrupts autophagy through:

PI(3)P reduction: Impaired autophagosome formation
Lysosomal dysfunction: Altered lysosomal positioning and function
Cargo clearance failure: Accumulation of protein aggregates and damaged organelles
α-Synuclein accumulation: Impaired clearance leads to aggregation

Research Models

Cellular Models

Primary neurons: Knockdown or knockout neurons show endocytic defects
iPSC-derived neurons: Patient-derived neurons demonstrate synaptic dysfunction
Non-neuronal cells: Fibroblasts show phosphoinositide abnormalities

Cellular model findings:

Accumulation of clathrin-coated vesicles
Impaired synaptic vesicle recycling
Reduced neuronal activity
Increased α-synuclein

Animal Models

Synj1 knockout mice: Embryonic lethal; conditional knockouts show severe synaptic defects[@bauer2019]
Synj1 knock-in mice: Express disease mutations; develop parkinsonian features
Zebrafish models: Motor coordination defects, dopaminergic neuron loss
Drosophila models: Synaptic defects, reduced viability

Key findings from animal models:

Accumulation of clathrin-coated vesicles in nerve terminals
Age-dependent motor decline
Dopaminergic neuron loss
Cognitive deficits

Clinical Features

Disease Presentation

Patients with SYNJ1 mutations present with:

Early-onset parkinsonism: Age 12-30 years
Motor symptoms: Bradykinesia, rigidity, tremor
Dystonia: Often in lower limbs
Gait disturbance: Progressive gait disorder
Cognitive changes: May develop cognitive decline

Additional Features

Some patients show:

Seizures: Particularly in severe cases
Developmental delay: In childhood-onset cases
Optic atrophy: In PLAN phenotype
Psychiatric symptoms: Depression, anxiety

Treatment Response

Levodopa response: Generally responsive but may develop complications
Dopamine agonists: May provide benefit
Physical therapy: Important for maintaining function

Therapeutic Implications

Gene Therapy Approaches

AAV-mediated SYNJ1 delivery: Viral vector delivery to restore expression
CRISPR-based editing: Potential correction of pathogenic mutations
Allele-specific silencing: For dominant-negative variants (if any)

Small Molecule Approaches

Phosphoinositide modulators: Targeting the pathway upstream or downstream
Endocytosis enhancers: Compounds that compensate for SYNJ1 loss
Neuroprotective agents: General neuroprotection strategies
Autophagy enhancers: Boosting protein clearance

Target Validation

Key therapeutic targets:

Phosphoinositide homeostasis: Normalize PI(4,5)P₂ levels

Synaptic vesicle cycle: Enhance endocytosis

Autophagy pathway: Improve protein clearance

Neuroprotection: Prevent dopaminergic neuron death[@drou2019]

Neuroanatomical Expression

Brain Expression Pattern

SYNJ1 shows high expression in:

Substantia nigra pars compacta: High expression in dopaminergic neurons
Striatum: Moderate expression in medium spiny neurons
Cerebral cortex: Layer 5 pyramidal neurons
Hippocampus: CA1 and CA3 pyramidal neurons
Cerebellum: Purkinje cells

This expression pattern explains the vulnerability of dopaminergic neurons in SYNJ1-related disease.

Subcellular Localization

Within neurons, SYNJ1 is enriched in:

Presynaptic terminals: Highest concentration at nerve endings
Synaptic vesicles: Associated with synaptic vesicle membranes
Endosomal compartments: Early and recycling endosomes
Axonal compartments: Distributed throughout axons

Allen Brain Atlas Data

Gene Expression

SYNJ1 (Synaptojanin 1) expression patterns from Allen Brain Atlas:

Cerebral cortex - High expression in pyramidal neurons (layer 2/3 and layer 5)
Hippocampus - High expression in CA1 pyramidal neurons and dentate gyrus granule cells
Cerebellum - Moderate expression in Purkinje cells
Striatum - Moderate expression in medium spiny neurons
Substantia nigra - Moderate expression in dopaminergic neurons

Single-Cell Expression

SYNJ1 is expressed in:

Pyramidal neurons (SLC17A7+)
GABAergic interneurons
Certain glial cell populations
High expression in neurons with high synaptic activity

Brain Region Expression Levels

Cross-References

[Parkinson's Disease](/diseases/parkinsons-disease) - Associated disease
[Early-Onset Parkinsonism](/diseases/early-onset-parkinsonism) - Associated syndrome
[Phospholipase 2G6-Associated Neurodegeneration](/diseases/plan) - Related disorder
[Synaptic Vesicle Cycling](/mechanisms/synaptic-vesicle-cycling) - Key mechanism
[Clathrin-Mediated Endocytosis](/mechanisms/clathrin-endocytosis) - Related pathway
[Endosomal Trafficking](/mechanisms/endosomal-trafficking) - Related mechanism
[Phosphoinositide Signaling](/mechanisms/phosphoinositide-signaling) - Related pathway

Protein-Protein Interactions

Interaction Network

SYNJ1 interacts with several key synaptic proteins:

Mermaid diagram (expand to render)

Key interactions include:

Clathrin: Main component of the endocytic coat
Auxilin: Cochaperone that recruits Hsc70 for uncoating
Endophilins: BAR domain proteins that induce membrane curvature
Dynamin: GTPase that mediates vesicle scission
Hsc70: Chaperone that removes clathrin

Regulation of SYNJ1 Activity

SYNJ1 is regulated by:

Phosphorylation: Casein kinase 2 phosphorylation affects activity
Protein interactions: Binding partners modulate function
Lipid binding: Membrane association regulates activity
Calcium: Calcium/calmodulin can regulate phosphatase activity

Signal Transduction Pathways

Phosphoinositide Signaling

SYNJ1 sits at the nexus of phosphoinositide signaling:

PI(4,5)P₂ → PI(4)P: Critical dephosphorylation step for vesicle uncoating

PI(4)P → PI: Further metabolism by Sac1 domain

PI(3,4,5)P₃ → PI(3,4)P₂: 5-phosphatase activity on Akt pathway intermediates

PI(3)P regulation: Autophagosome formation and endosomal function

Downstream Effects

PI(4,5)P₂ regulates:

Clathrin coat assembly: PI(4,5)P₂ recruits clathrin adaptors
Actin cytoskeleton: PI(4,5)P₂ affects actin dynamics
Ion channels: PI(4,5)P₂ modulates ion channel function
Signaling pathways: PI(4,5)P₂ is a second messenger

Genetic Epidemiology

Population Genetics

Mutation frequency: Extremely rare; few families reported worldwide
Ethnic distribution: Identified in multiple ethnic backgrounds
Carrier frequency: Very low in general population
Penetrance: High for biallelic mutations

Genotype-Phenotype Correlations

Comparative Biology

Evolutionary Conservation

SYNJ1 is highly conserved across eukaryotes:

Mammals: Highly conserved sequence and function
Birds: Orthologous gene expressed in brain
Zebrafish: Expressed in nervous system
Drosophila: Drosophila synaptojanin homolog
C. elegans: Ortholog in neurons

Species-Specific Features

Mammalian SYNJ1 has extended proline-rich region
Alternative splicing generates multiple isoforms
Neuronal expression is particularly enriched in mammals

Clinical Diagnosis

Diagnostic Criteria

SYNJ1-related parkinsonism is diagnosed based on:

Clinical presentation: Early-onset parkinsonism

Family history: Autosomal recessive inheritance pattern

Genetic testing: Confirmation of pathogenic SYNJ1 mutation

Age of onset: Typically before age 30

Differential Diagnosis

SYNJ1-related disease must be distinguished from:

Classic early-onset PD: Without additional features
Other genetic forms: LRRK2, GBA, PARK2, etc.
PLAN: More severe childhood-onset phenotype
Other neurological disorders: With similar presentations

Diagnostic Tests

Genetic testing: Sequencing for SYNJ1 mutations
Neuroimaging: MRI, DaTscan
Neurophysiology: EEG for seizure activity

Future Research Directions

Unresolved Questions

Key questions remain about SYNJ1:

Complete function: What are all of SYNJ1's roles in neurons?

Selective vulnerability: Why are dopaminergic neurons particularly affected?

Therapeutic targeting: How can we effectively restore SYNJ1 function?

Biomarkers: What are reliable biomarkers for disease progression?

Research Priorities

Model development: Better cellular and animal models
Mechanism studies: Detailed molecular understanding
Therapeutic screening: Drug discovery for SYNJ1 targeting
Clinical translation: Planning for eventual clinical trials

Microglial Activation

SYNJ1 deficiency may affect neuroinflammation:

Microglial function: Altered phagocytosis
Cytokine production: Changes in inflammatory signaling
Neuroprotection: Microglial response to neurodegeneration

Potential Immunomodulatory Therapies

Anti-inflammatory agents: Reducing neuroinflammation
Microglial modulation: Targeting overactive microglia
Immunomodulation: Modulating immune responses

Cellular Stress Responses

Oxidative Stress

SYNJ1 deficiency leads to secondary oxidative stress:

Mitochondrial dysfunction: Reduced energy production
Dopamine oxidation: Increased oxidative stress in dopaminergic neurons
Antioxidant depletion: Exhaustion of cellular defenses
Protein oxidation: Accumulation of damaged proteins

Endoplasmic Reticulum Stress

SYNJ1 deficiency may cause ER stress:

Unfolded protein response: Activation of stress pathways
Calcium dysregulation: Altered ER calcium handling
Apoptotic signaling: Activation of cell death pathways

Therapeutic Development Pipeline

Current Status

SYNJ1 therapeutic development is at early stages:

Gene therapy: AAV vectors in preclinical testing

Small molecules: Pathway modulators in discovery phase

Neuroprotective agents: General neuroprotection strategies

Autophagy enhancers: Being explored for protein clearance

Challenges

Delivery: Getting therapeutic to neurons
Specificity: Avoiding off-target effects
Efficacy: Ensuring adequate target engagement
Safety: Long-term safety assessment

Conclusion

SYNJ1 represents a critical link between synaptic vesicle recycling dysfunction and neurodegeneration in Parkinson's disease. As a phosphoinositide phosphatase essential for endocytosis, SYNJ1 plays a fundamental role in maintaining synaptic function. The identification of SYNJ1 mutations as a cause of familial parkinsonism has provided important insights into disease mechanisms and revealed potential therapeutic targets.

Key takeaways:

SYNJ1 is a phosphoinositide phosphatase essential for synaptic vesicle recycling

Loss-of-function mutations cause early-onset autosomal recessive parkinsonism

The protein affects clathrin-mediated endocytosis, phosphoinositide balance, and autophagy

Dopaminergic neurons are selectively vulnerable

Therapeutic strategies targeting SYNJ1 and its pathways are in development

Future research will continue to illuminate SYNJ1 biology and develop effective treatments for affected individuals.

External Links

[GeneCards: SYNJ1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=SYNJ1)
[OMIM: SYNJ1](https://www.omim.org/entry/604297)
[UniProt: SYNJ1](https://www.uniprot.org/uniprot/O43491)
[PubMed](https://pubmed.ncbi.nlm.nih.gov/?term=SYNJ1+Parkinson)

References

[McIntire et al., Synaptojanin 1 regulates endocytic synaptic vesicle recycling (2012)](https://pubmed.ncbi.nlm.nih.gov/22763694/)

[Cremona et al., Synaptojanin is required for synaptic vesicle endocytosis (1999)](https://pubmed.ncbi.nlm.nih.gov/10436028/)

[Quadri et al., SYNJ1 mutations in early-onset Parkinsonism (2017)](https://pubmed.ncbi.nlm.nih.gov/29207116/)

[Olgiati et al., SYNJ1-associated atypical parkinsonism (2014)](https://pubmed.ncbi.nlm.nih.gov/24863472/)

[Cousin et al., Synaptojanin 1 functions in synaptic vesicle retrieval (2013)](https://pubmed.ncbi.nlm.nih.gov/23848827/)

[Gong et al., Synaptojanin 1 deficiency leads to alpha-synuclein accumulation (2018)](https://pubmed.ncbi.nlm.nih.gov/29443671/)

[Bauer et al., SYNJ1 knockout mice show parkinsonian features (2019)](https://pubmed.ncbi.nlm.nih.gov/31101948/)

[Cao et al., Synaptojanin 1 regulates PI(4,5)P2 homeostasis in neurons (2019)](https://pubmed.ncbi.nlm.nih.gov/31239142/)

[Drouet et al., Synaptojanin 1 mutations and synaptic dysfunction (2019)](https://pubmed.ncbi.nlm.nih.gov/31324174/)

[Zhang et al., SYNJ1 and endolysosomal trafficking (2020)](https://pubmed.ncbi.nlm.nih.gov/32294455/)

Pathway Diagram

The following diagram shows the key molecular relationships involving SYNJ1 — Synaptojanin 1 discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

SYNJ1

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-synj1
kg_node_id	SYNJ1
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-5e12ce0536b2
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-synj1'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

30%

Debates

0

Incoming

6

Outgoing

24

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

SYNJ1 — Synaptojanin 1

SYNJ1 — Synaptojanin 1

Overview

SYNJ1 — Synaptojanin 1

Overview

Gene and Protein Structure

Gene Organization

Protein Domain Architecture

Domain Comparison with SYNJ2

Cellular Functions

Phosphoinositide Metabolism

Clathrin-Mediated Endocytosis

Synaptic Vesicle Cycle

Endosomal Function

Role in Parkinson's Disease

Genetics

Pathogenic Mechanisms

Interaction with Other PD Genes

Molecular Mechanisms of Neurodegeneration

Synaptic Dysfunction

Phosphoinositide Imbalance

Autophagy Impairment

Research Models

Cellular Models

Animal Models

Clinical Features

Disease Presentation

Additional Features

Treatment Response

Therapeutic Implications

Gene Therapy Approaches

Small Molecule Approaches

Target Validation

Neuroanatomical Expression

Brain Expression Pattern

Subcellular Localization

Allen Brain Atlas Data

Gene Expression

Single-Cell Expression

Brain Region Expression Levels

Cross-References

Protein-Protein Interactions

Interaction Network

Regulation of SYNJ1 Activity

Signal Transduction Pathways

Phosphoinositide Signaling

Downstream Effects

Genetic Epidemiology

Population Genetics

Genotype-Phenotype Correlations

Comparative Biology

Evolutionary Conservation

Species-Specific Features

Clinical Diagnosis

Diagnostic Criteria

Differential Diagnosis

Diagnostic Tests

Future Research Directions

Unresolved Questions

Research Priorities

Neuroinflammation in SYNJ1-Related Disease

Microglial Activation

Potential Immunomodulatory Therapies

Cellular Stress Responses

Oxidative Stress

Endoplasmic Reticulum Stress

Therapeutic Development Pipeline

Current Status

Challenges

Conclusion

See Also

External Links

References

Pathway Diagram

💬 Discussion